email-template-logo-black
FF-EmailHeros_Lung-05

JOIN US
Fusion Detection in Advanced NSCLC: Stay Up to Date

Targetable drivers in non-small cell lung cancer include ALK, RET, and ROS1 fusions—do you know how to detect them? DNA-based and RNA-based sequencing each have advantages and drawbacks when it comes to fusion detection. In this webinar, expert speakers will present their perspectives on fusion detection using next-generation sequencing in NSCLC.

May 22, 2024

3:30 pm ET

Presented by:

Headshot-MarkSocinski

MARK A. SOCINSKI, MD
Internationally Recognized Expert
in Lung Cancer

Headshot-Wong_Katy

KATY WONG, PhD
Director, Medical Field Team
Foundation Medicine

Headshot-JenniferMills

JENNIFER MILLS, PhD
Moderator
Vice President, Medical Affairs,
Foundation Medicine
 

Registration Form